Literature DB >> 27905476

Heart failure: Neprilysin inhibition attenuates risk of hyperkalaemia in HFrEF.

Karina Huynh.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27905476     DOI： 10.1038/nrcardio.2016.196

Source DB:  PubMed          Journal:  Nat Rev Cardiol        ISSN： 1759-5002            Impact factor:   32.419


× No keyword cloud information.
  1 in total

1.  Reduced Risk of Hyperkalemia During Treatment of Heart Failure With Mineralocorticoid Receptor Antagonists by Use of Sacubitril/Valsartan Compared With Enalapril: A Secondary Analysis of the PARADIGM-HF Trial.

Authors:  Akshay S Desai; Orly Vardeny; Brian Claggett; John J V McMurray; Milton Packer; Karl Swedberg; Jean L Rouleau; Michael R Zile; Martin Lefkowitz; Victor Shi; Scott D Solomon
Journal:  JAMA Cardiol       Date:  2017-01-01       Impact factor: 14.676
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.